DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| Year-End Report (this page) | Jan 23, 2008 | $100,000 | Replaced |
| Year-End Report | Jan 30, 2008 | $100,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Health Issues HCR
Project BioShield, Biodefense vaccine and biological product R&D, procurement for the Strategic National Stockpile, and product liability related oversight, authorizing, and appropriations legislation; DHHS and CDC procurement of anthrax vaccines
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Homeland Security HOM
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Medical/Disease Research/Clinical Labs MED
Biodefense R&D Vaccine and Biological Product funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.